Alzamend Neuro Inc
General ticker "ALZN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.6M
Alzamend Neuro Inc does not follow the US Stock Market performance with the rate: -38.6%.
Estimated limits based on current volatility of 4.6%: low 1.15$, high 1.26$
Factors to consider:
- Current price 66.8% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-04-30 to 2026-04-30
- 2024-04-30 to 2025-04-30 estimated range: [3.47$, 14.56$]
- 2025-04-30 to 2026-04-30 estimated range: [2.58$, 9.43$]
Financial Metrics affecting the ALZN estimates:
- Negative: Non-GAAP EPS, $ of -13.89 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -59.52 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -24.53 <= 3.85
- Negative: Industry earnings per price (median), % of -25.46 <= 1.31
- Negative: 0 < Interest expense per share, $ of 0.01
- Positive: -0.96 < Investing cash flow per share, $ of -0.22
Short-term ALZN quotes
Long-term ALZN plot with estimates
Financial data
| YTD | 2022-04-30 | 2023-04-30 | 2024-04-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $12.32MM | $14.87MM | $9.94MM |
| Operating Income | $-12.32MM | $-14.87MM | $-9.94MM |
| Non-Operating Income | $-0.04MM | $-0.01MM | $-0.01MM |
| Interest Expense | $0.05MM | $0.01MM | $0.01MM |
| R&D Expense | $5.20MM | $7.45MM | $6.46MM |
| Income(Loss) | $-12.36MM | $-14.88MM | $-9.95MM |
| Profit(Loss) | $-12.36MM | $-14.88MM | $-9.95MM |
| Stockholders Equity | $13.35MM | $3.05MM | $-2.59MM |
| Assets | $14.52MM | $5.92MM | $0.63MM |
| Operating Cash Flow | $-6.61MM | $-8.92MM | $-8.27MM |
| Capital expenditure | $0.11MM | $0.00MM | $0.15MM |
| Investing Cash Flow | $-0.11MM | $0.00MM | $-0.15MM |
| Financing Cash Flow | $18.85MM | $0.00MM | $3.65MM |
| Earnings Per Share* | $-20.92 | $-22.89 | $-14.72 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.